ResMed is betting big on artificial intelligence (AI) to boost CPAP adherence. At the recent J.P. Morgan Healthcare Conference, CEO Mick Farrell said the company’s first AI-enabled medical device, Sma ...
2030 ambition to help more than 500 million people worldwide achieve their full health potential Showcases integration of intelligent products and solutions within the ResMed ecosystem, designed to ...
StockStory.org on MSN
Reflecting on patient monitoring stocks’ Q3 earnings: ResMed (NYSE:RMD)
With Q3 behind us, let’s have a look at ResMed (NYSE:RMD) and its peers. Patient monitoring companies within the healthcare ...
ResMed's fifth annual Global Sleep Survey highlights a significant global sleep crisis, revealing that 71% of employed individuals have called in sick at least once due to poor sleep, with the average ...
NEW DELHI--(BUSINESS WIRE)--ResMed, a world leader in connected health solutions for sleep apnea, lung disease, and other chronic diseases, today announced the appointment of Shubhi Khurana as general ...
With the pedal firmly to the metal in its U.S. business—thanks in no small part to rival CPAP machine maker Philips’ ongoing recall—ResMed has begun looking beyond its home turf to extend that winning ...
Connected respiratory device maker ResMed signed a definitive agreement to acquire Medifox Dan, a German out-of-hospital software company, from software investor Hg for $1 billion (€950 million).
SYDNEY--(BUSINESS WIRE)--ResMed today announced it has teamed up with Rugby League Hall of Fame inductee, current NSW Blues State of Origin head coach, and Channel 9 commentator Brad Fittler to help ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback